203 related articles for article (PubMed ID: 36585629)
1. A phase III, multicenter, randomized controlled trial of preoperative versus postoperative stereotactic radiosurgery for patients with surgically resectable brain metastases.
Das S; Faruqi S; Nordal R; Starreveld Y; Kelly J; Bowden G; Amanie J; Fairchild A; Lim G; Loewen S; Rowe L; Wallace C; Ghosh S; Patel S
BMC Cancer; 2022 Dec; 22(1):1368. PubMed ID: 36585629
[TBL] [Abstract][Full Text] [Related]
2. Hypofractionated stereotactic radiotherapy (HFSRT) versus single fraction stereotactic radiosurgery (SRS) to the resection cavity of brain metastases after surgical resection (SATURNUS): study protocol for a randomized phase III trial.
Waltenberger M; Bernhardt D; Diehl C; Gempt J; Meyer B; Straube C; Wiestler B; Wilkens JJ; Zimmer C; Combs SE
BMC Cancer; 2023 Jul; 23(1):709. PubMed ID: 37516835
[TBL] [Abstract][Full Text] [Related]
3. Comparison of preoperative versus postoperative treatment dosimetry plans of single-fraction stereotactic radiosurgery for surgically resected brain metastases.
Cheok SK; Yu C; Feng JJ; Briggs RG; Chow F; Hwang L; Ye JC; Attenello FJ; Tran D; Chang E; Zada G
Neurosurg Focus; 2023 Aug; 55(2):E9. PubMed ID: 37527673
[TBL] [Abstract][Full Text] [Related]
4. SAFESTEREO: phase II randomized trial to compare stereotactic radiosurgery with fractionated stereotactic radiosurgery for brain metastases.
Crouzen JA; Petoukhova AL; Broekman MLD; Fiocco M; Fisscher UJ; Franssen JH; Gadellaa-van Hooijdonk CGM; Kerkhof M; Kiderlen M; Mast ME; van Rij CM; Nandoe Tewarie R; van de Sande MAE; van der Toorn PPG; Vlasman R; Vos MJ; van der Voort van Zyp NCMG; Wiggenraad RGJ; Wiltink LM; Zindler JD
BMC Cancer; 2023 Mar; 23(1):273. PubMed ID: 36964529
[TBL] [Abstract][Full Text] [Related]
5. Risk Factors for Progression and Toxic Effects After Preoperative Stereotactic Radiosurgery for Patients With Resected Brain Metastases.
Prabhu RS; Akinyelu T; Vaslow ZK; Matsui JK; Haghighi N; Dan T; Mishra MV; Murphy ES; Boyles S; Perlow HK; Palmer JD; Udovicich C; Patel TR; Wardak Z; Woodworth GF; Ksendzovsky A; Yang K; Chao ST; Asher AL; Burri SH
JAMA Oncol; 2023 Aug; 9(8):1066-1073. PubMed ID: 37289451
[TBL] [Abstract][Full Text] [Related]
6. Pre-operative vs. post-operative stereotactic radiosurgery for operative metastatic brain tumors: study protocol for a phase III clinical trial.
Routman DM; Jusue-Torres I; Brown PD; Trifiletti DM; Vora SA; Brown DA; Parney IF; Burns TC; Yan E
BMC Cancer; 2024 Mar; 24(1):332. PubMed ID: 38475765
[TBL] [Abstract][Full Text] [Related]
7. Comparing Preoperative With Postoperative Stereotactic Radiosurgery for Resectable Brain Metastases: A Multi-institutional Analysis.
Patel KR; Burri SH; Asher AL; Crocker IR; Fraser RW; Zhang C; Chen Z; Kandula S; Zhong J; Press RH; Olson JJ; Oyesiku NM; Wait SD; Curran WJ; Shu HK; Prabhu RS
Neurosurgery; 2016 Aug; 79(2):279-85. PubMed ID: 26528673
[TBL] [Abstract][Full Text] [Related]
8. Early Gamma Knife stereotactic radiosurgery to the tumor bed of resected brain metastasis for improved local control.
Iorio-Morin C; Masson-Côté L; Ezahr Y; Blanchard J; Ebacher A; Mathieu D
J Neurosurg; 2014 Dec; 121 Suppl():69-74. PubMed ID: 25434939
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of pre-operative stereotactic radiosurgery followed by surgical resection and correlative radiobiological analysis for patients with 1-4 brain metastases: study protocol for a phase II trial.
Huff WX; Agrawal N; Shapiro S; Miller J; Kulwin C; Shah M; Savage JJ; Payner T; Vortmeyer A; Watson G; Dey M
Radiat Oncol; 2018 Dec; 13(1):252. PubMed ID: 30572923
[TBL] [Abstract][Full Text] [Related]
10. Single-Fraction Versus Fractionated Preoperative Radiosurgery for Resected Brain Metastases: A PROPS-BM International Multicenter Cohort Study.
Prabhu RS; Akinyelu T; Vaslow ZK; Matsui JK; Haghighi N; Dan T; Mishra MV; Murphy ES; Boyles S; Perlow HK; Palmer JD; Udovicich C; Patel TR; Wardak Z; Woodworth GF; Ksendzovsky A; Yang K; Chao ST; Asher AL; Burri SH
Int J Radiat Oncol Biol Phys; 2024 Mar; 118(3):650-661. PubMed ID: 37717787
[TBL] [Abstract][Full Text] [Related]
11. Current status and recent advances in resection cavity irradiation of brain metastases.
Minniti G; Niyazi M; Andratschke N; Guckenberger M; Palmer JD; Shih HA; Lo SS; Soltys S; Russo I; Brown PD; Belka C
Radiat Oncol; 2021 Apr; 16(1):73. PubMed ID: 33858474
[TBL] [Abstract][Full Text] [Related]
12. Preoperative stereotactic radiosurgery before planned resection of brain metastases: updated analysis of efficacy and toxicity of a novel treatment paradigm.
Prabhu RS; Miller KR; Asher AL; Heinzerling JH; Moeller BJ; Lankford SP; McCammon RJ; Fasola CE; Patel KR; Press RH; Sumrall AL; Ward MC; Burri SH
J Neurosurg; 2018 Dec; 131(5):1387-1394. PubMed ID: 30554174
[TBL] [Abstract][Full Text] [Related]
13. Postoperative stereotactic radiosurgery for resected brain metastases: A comparison of outcomes for large resection cavities.
Zhong J; Ferris MJ; Switchenko J; Press RH; Buchwald Z; Olson JJ; Eaton BR; Curran WJ; Shu HG; Crocker IR; Patel KR
Pract Radiat Oncol; 2017; 7(6):e419-e425. PubMed ID: 28668668
[TBL] [Abstract][Full Text] [Related]
14. Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC·3): a multicentre, randomised, controlled, phase 3 trial.
Brown PD; Ballman KV; Cerhan JH; Anderson SK; Carrero XW; Whitton AC; Greenspoon J; Parney IF; Laack NNI; Ashman JB; Bahary JP; Hadjipanayis CG; Urbanic JJ; Barker FG; Farace E; Khuntia D; Giannini C; Buckner JC; Galanis E; Roberge D
Lancet Oncol; 2017 Aug; 18(8):1049-1060. PubMed ID: 28687377
[TBL] [Abstract][Full Text] [Related]
15. Neoadjuvant stereotactic radiosurgery for intracerebral metastases of solid tumors (NepoMUC): a phase I dose escalation trial.
Diehl CD; Shiban E; Straube C; Gempt J; Wilkens JJ; Oechsner M; Kessel C; Zimmer C; Wiestler B; Meyer B; Combs SE
Cancer Commun (Lond); 2019 Nov; 39(1):73. PubMed ID: 31706337
[TBL] [Abstract][Full Text] [Related]
16. Comparative effectiveness of multi-fraction stereotactic radiosurgery for surgically resected or intact large brain metastases from non-small-cell lung cancer (NSCLC).
Minniti G; Scaringi C; Lanzetta G; Anzellini D; Bianciardi F; Tolu B; Morace R; Romano A; Osti M; Gentile P; Paolini S
Lung Cancer; 2019 Jun; 132():119-125. PubMed ID: 31097084
[TBL] [Abstract][Full Text] [Related]
17. Stereotactic radiosurgery to the resection bed for intracranial metastases and risk of leptomeningeal carcinomatosis.
Ojerholm E; Lee JY; Thawani JP; Miller D; O'Rourke DM; Dorsey JF; Geiger GA; Nagda S; Kolker JD; Lustig RA; Alonso-Basanta M
J Neurosurg; 2014 Dec; 121 Suppl():75-83. PubMed ID: 25434940
[TBL] [Abstract][Full Text] [Related]
18. Post-operative stereotactic radiosurgery versus observation for completely resected brain metastases: a single-centre, randomised, controlled, phase 3 trial.
Mahajan A; Ahmed S; McAleer MF; Weinberg JS; Li J; Brown P; Settle S; Prabhu SS; Lang FF; Levine N; McGovern S; Sulman E; McCutcheon IE; Azeem S; Cahill D; Tatsui C; Heimberger AB; Ferguson S; Ghia A; Demonte F; Raza S; Guha-Thakurta N; Yang J; Sawaya R; Hess KR; Rao G
Lancet Oncol; 2017 Aug; 18(8):1040-1048. PubMed ID: 28687375
[TBL] [Abstract][Full Text] [Related]
19. Whole Brain Radiotherapy Versus Stereotactic Radiosurgery in Poor-Prognosis Patients with One to 10 Brain Metastases: A Randomised Feasibility Study.
Raman S; Mou B; Hsu F; Valev B; Cheung A; Vallières I; Ma R; McKenzie M; Beaton L; Rackley T; Gondara L; Nichol A
Clin Oncol (R Coll Radiol); 2020 Jul; 32(7):442-451. PubMed ID: 32085923
[TBL] [Abstract][Full Text] [Related]
20. Neoadjuvant stereotactic radiosurgery for brain metastases: a new paradigm.
Li YD; Coxon AT; Huang J; Abraham CD; Dowling JL; Leuthardt EC; Dunn GP; Kim AH; Dacey RG; Zipfel GJ; Evans J; Filiput EA; Chicoine MR
Neurosurg Focus; 2022 Nov; 53(5):E8. PubMed ID: 36321291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]